Synaptics officer plans sale of 334 shares

SYNAPTICS Inc (SYNA) received a notice that officer Lisa Bodensteiner plans to sell 334 shares of common stock under Rule 144 through Morgan Stanley Smith Barney, with an indicated value of 30,434.08.

Available on EDGAR 09/18/2026 - 04:18 PM EDT Accepted by SEC EDGAR 09/18/2026 - 04:17 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

SYNAPTICS Inc (SYNA) received a notice that officer Lisa Bodensteiner plans to sell 334 shares of common stock under Rule 144 through Morgan Stanley Smith Barney, with an indicated value of 30,434.08. The shares relate to Restricted Stock Units dated September 17, 2026, and follow prior 10b5-1 plan sales in recent months.

Key Figures

Planned shares to be sold: 334 shares Indicated value of planned sale: 30,434.08 10b5-1 sale on August 18, 2026: 6,056 shares; 627,530.59 +3 more

6 metrics

Planned shares to be sold 334 shares Common stock to be sold under Rule 144 related to RSUs dated September 17, 2026

Indicated value of planned sale 30,434.08 Value associated with 334 shares of common stock in the Rule 144 notice

10b5-1 sale on August 18, 2026 6,056 shares; 627,530.59 Common stock sold by Lisa Bodensteiner under a 10b5-1 plan

10b5-1 sale on July 20, 2026 450 shares; 51,735.20 Common stock sold by Lisa Bodensteiner under a 10b5-1 plan

Issuer phone number 408-904-1100 Contact phone for Synaptics Inc

Planned sale date reference September 18, 2026 Date associated with the Rule 144 securities information section

Key Terms

Rule 144, Restricted Stock Units, 10b5-1

3 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Restricted Stock Units financial

"Common | 09/17/2026 | Restricted Stock Units | Issuer"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

10b5-1 regulatory

"10b5-1 Sales for LISA BODENSTEINER 1109 McKay Drive San Jose CA 95131"

A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing for SYNA disclose about planned sales?

The notice states that officer Lisa Bodensteiner plans to sell 334 shares of Synaptics common stock under Rule 144, with an indicated value of 30,434.08, through Morgan Stanley Smith Barney, related to Restricted Stock Units dated September 17, 2026.

How many SYNA shares has Lisa Bodensteiner sold in the past three months?

The filing lists two prior 10b5-1 sales: 6,056 shares of Synaptics common stock on August 18, 2026 for 627,530.59, and 450 shares on July 20, 2026 for 51,735.20.

What type of SYNA security is involved in the new Form 144 sale?

The security is common stock of Synaptics Inc, tied to Restricted Stock Units dated September 17, 2026, with 334 shares noted as the amount to be sold under Rule 144.

Which broker is handling the planned SYNA stock sale under Rule 144?

The planned sale of 334 shares of Synaptics common stock is to be executed through Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, New York.

When were the recent 10b5-1 plan sales of SYNA shares executed?

The filing reports 10b5-1 plan sales for Lisa Bodensteiner on August 18, 2026 and July 20, 2026, involving 6,056 shares and 450 shares of Synaptics common stock, respectively.

What relationship does the selling person have with SYNA?

The selling person, Lisa Bodensteiner, is identified in the filing as an Officer of Synaptics Inc, providing the role context for the reported Rule 144 and 10b5-1 plan sales.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001213272
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	SYNAPTICS INCORPORATED
SEC File Number	000-49602
Address of Issuer	1109 McKay Drive San Jose CALIFORNIA 95131
Phone	4089041100
Name of Person for Whose Account the Securities are To Be Sold	LISA BODENSTEINER
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	334	30434.08	39106986	09/18/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/17/2026	Restricted Stock Units	Issuer			334	09/17/2026	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for LISA BODENSTEINER 1109 McKay Drive San Jose CA 95131	Common	08/18/2026	6056	627530.59
10b5-1 Sales for LISA BODENSTEINER 1109 McKay Drive San Jose CA 95131	Common	07/20/2026	450	51735.20

144: Remarks and Signature

Remarks
Date of Notice	09/18/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	09/09/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Lisa Bodensteiner
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)